Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Roberto Gerli and Carlo Perricone.
Roberto Gerli
Connection Strength
5.880
Carlo Perricone
  1. Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'. Ann Rheum Dis. 2021 Jan 28.
    View in: PubMed
    Score: 0.926
  2. Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia. 2020; 58(5):261-264.
    View in: PubMed
    Score: 0.909
  3. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020 08; 68(4):213-224.
    View in: PubMed
    Score: 0.895
  4. The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart. Clin Exp Rheumatol. 2020 May-Jun; 38(3):580.
    View in: PubMed
    Score: 0.881
  5. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020 07; 111:102468.
    View in: PubMed
    Score: 0.877
  6. Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19. Eur J Rheumatol. 2020 Aug; 7(Suppl 2):S89-S90.
    View in: PubMed
    Score: 0.876
  7. Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections. Microorganisms. 2021 Jan 07; 9(1).
    View in: PubMed
    Score: 0.231
  8. Hypertension and SARS-CoV-2 infection: is inflammation the missing link? Cardiovasc Res. 2020 11 01; 116(13):e193-e194.
    View in: PubMed
    Score: 0.228
  9. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases. Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):754-759.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.